SPX Acquires Anhydro
SPX said that the transaction includes all Anhydro’s business units with the exception of its Danish Filter business, Simatek, and its German, UK and US operations, as well
Faeth Therapeutics has received the US Food and Drug Administration’s (FDA) fast track designation for the sapanisertib and serabelisib (PIKTOR) with paclitaxel combination to treat advanced or recurrent endometrial cancer.